GB9211081D0 - Vaccines - Google Patents

Vaccines

Info

Publication number
GB9211081D0
GB9211081D0 GB929211081A GB9211081A GB9211081D0 GB 9211081 D0 GB9211081 D0 GB 9211081D0 GB 929211081 A GB929211081 A GB 929211081A GB 9211081 A GB9211081 A GB 9211081A GB 9211081 D0 GB9211081 D0 GB 9211081D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929211081A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GB929211081A priority Critical patent/GB9211081D0/en
Publication of GB9211081D0 publication Critical patent/GB9211081D0/en
Priority to ES93912750T priority patent/ES2118963T3/en
Priority to ES97204034T priority patent/ES2334181T3/en
Priority to EP10179579A priority patent/EP2289548A3/en
Priority to AT97204034T priority patent/ATE444079T1/en
Priority to DE69334297T priority patent/DE69334297D1/en
Priority to KR1019940704215A priority patent/KR100287083B1/en
Priority to UA94129182A priority patent/UA40596C2/en
Priority to PL93306304A priority patent/PL174077B1/en
Priority to DK93912750T priority patent/DK0642355T3/en
Priority to DE122010000015C priority patent/DE122010000015I1/en
Priority to RU94046145/63K priority patent/RU2287344C2/en
Priority to CZ942892A priority patent/CZ283910B6/en
Priority to AT93912750T priority patent/ATE168271T1/en
Priority to CA002136429A priority patent/CA2136429C/en
Priority to HU9403366A priority patent/HU220236B/en
Priority to DE122010000016C priority patent/DE122010000016I1/en
Priority to NZ253065A priority patent/NZ253065A/en
Priority to PCT/EP1993/001276 priority patent/WO1993024148A1/en
Priority to AU43156/93A priority patent/AU4315693A/en
Priority to EP97204034A priority patent/EP0835663B1/en
Priority to PT97204034T priority patent/PT835663E/en
Priority to SG1996009149A priority patent/SG48365A1/en
Priority to JP50016294A priority patent/JP3626996B2/en
Priority to EP09171545A priority patent/EP2156845A1/en
Priority to RU94046145/13A priority patent/RU2160120C2/en
Priority to EP93912750A priority patent/EP0642355B1/en
Priority to DE69319728T priority patent/DE69319728T2/en
Priority to DK97204034.9T priority patent/DK0835663T3/en
Priority to SK1421-94A priority patent/SK280702B6/en
Priority to MYPI93000939A priority patent/MY110665A/en
Priority to APAP/P/1993/000530A priority patent/AP567A/en
Priority to SI9300271A priority patent/SI9300271A/en
Priority to ZA933541A priority patent/ZA933541B/en
Priority to MA23192A priority patent/MA22894A1/en
Priority to MX9302982A priority patent/MX9302982A/en
Priority to IL10577093A priority patent/IL105770A/en
Priority to CNB931073197A priority patent/CN1136918C/en
Priority to CNB031332374A priority patent/CN1313152C/en
Priority to FI945483A priority patent/FI945483A/en
Priority to NO944475A priority patent/NO309675B1/en
Priority to US08/755,927 priority patent/US6013264A/en
Priority to AU16480/97A priority patent/AU709406C/en
Priority to HK98112444A priority patent/HK1011290A1/en
Priority to HK00100138.3A priority patent/HK1021142A1/en
Priority to AU50629/02A priority patent/AU785433B2/en
Priority to AU2007201162A priority patent/AU2007201162A1/en
Priority to AU2010200249A priority patent/AU2010200249B2/en
Priority to LU91659C priority patent/LU91659I2/en
Priority to LU91658C priority patent/LU91658I2/en
Priority to CY1100003A priority patent/CY2614B2/en
Pending legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GB929211081A 1992-05-23 1992-05-23 Vaccines Pending GB9211081D0 (en)

Priority Applications (51)

Application Number Priority Date Filing Date Title
GB929211081A GB9211081D0 (en) 1992-05-23 1992-05-23 Vaccines
ES93912750T ES2118963T3 (en) 1992-05-23 1993-05-15 COMBINED VACCINES, CONTAINING HEPATITIS B SURFACE ANTIGEN AND OTHER ANTIGENS.
ES97204034T ES2334181T3 (en) 1992-05-23 1993-05-15 COMBINED VACCINES THAT INCLUDE HEPATITIS B SURFACE ANTIGEN AND OTHER ANTIGENS.
EP10179579A EP2289548A3 (en) 1992-05-23 1993-05-15 Combined vaccines comprising hepatitis B surface antigen and other antigens
AT97204034T ATE444079T1 (en) 1992-05-23 1993-05-15 COMBINED VACCINES CONTAINING HEPATITIS B SURFACE ANTIGEN AND OTHER ANTIGENS
DE69334297T DE69334297D1 (en) 1992-05-23 1993-05-15 Combined vaccines containing hepatitis B surface antigen and other antigens
KR1019940704215A KR100287083B1 (en) 1992-05-23 1993-05-15 Combination vaccine comprising hepatitis B surface antigen and other antigens
UA94129182A UA40596C2 (en) 1992-05-23 1993-05-15 Vaccine formulation and method for its preparing
PL93306304A PL174077B1 (en) 1992-05-23 1993-05-15 Vaccine for preventing or treating hepatitis b infections and heterologous diseases, containing hepatitis b surface antigen (hbsag)
DK93912750T DK0642355T3 (en) 1992-05-23 1993-05-15 Combined vaccines that include hepatitis B surface antigen and other antigens
DE122010000015C DE122010000015I1 (en) 1992-05-23 1993-05-15 Combined vaccines containing hepatitis B surface antigens and other antigens
RU94046145/63K RU2287344C2 (en) 1992-05-23 1993-05-15 Mixed vaccine based on hepatitis b virus surface antigen, method for its preparing and method for prophylaxis of hepatitis b infection in humans
CZ942892A CZ283910B6 (en) 1992-05-23 1993-05-15 Combined inoculation preparation
AT93912750T ATE168271T1 (en) 1992-05-23 1993-05-15 COMBINED VACCINES CONTAINING HEPATITIS B SURFACE ANTIGEN AND OTHER ANTIGENS
CA002136429A CA2136429C (en) 1992-05-23 1993-05-15 Combined vaccines comprising hepatitis b surface antigen and other antigens
HU9403366A HU220236B (en) 1992-05-23 1993-05-15 Combined vaccines comprising hepatitis b surface antigen and other antigens
DE122010000016C DE122010000016I1 (en) 1992-05-23 1993-05-15 Combined vaccines containing hepatitis B surface antigens and other antigens
NZ253065A NZ253065A (en) 1992-05-23 1993-05-15 Combination vaccines comprising hepatitis b surface antigens and other antigens wherein aluminium phosphate adjuvant is used to adsorb the hepatitis antigen
PCT/EP1993/001276 WO1993024148A1 (en) 1992-05-23 1993-05-15 Combined vaccines comprising hepatitis b surface antigen and other antigens
AU43156/93A AU4315693A (en) 1992-05-23 1993-05-15 Combined vaccines comprising hepatitis b surface antigen and other antigens
EP97204034A EP0835663B1 (en) 1992-05-23 1993-05-15 Combined vaccines comprising Hepatitis B surface antigen and other antigens
PT97204034T PT835663E (en) 1992-05-23 1993-05-15 Combined vaccines comprising hepatitis b surface antigen and other antigens
SG1996009149A SG48365A1 (en) 1992-05-23 1993-05-15 Combined vaccines comprising hepatitis b surface antigen and other antigens
JP50016294A JP3626996B2 (en) 1992-05-23 1993-05-15 Combined vaccine consisting of hepatitis B surface antigen and other antigens
EP09171545A EP2156845A1 (en) 1992-05-23 1993-05-15 Combined vaccines comprising hepatitis B surface antigen and other antigens
RU94046145/13A RU2160120C2 (en) 1992-05-23 1993-05-15 Combined vaccine based on surface hepatitis b virus antigen, method of preparation thereof, and method for preventing hepatitis b infection in man
EP93912750A EP0642355B1 (en) 1992-05-23 1993-05-15 Combined vaccines comprising hepatitis b surface antigen and other antigens
DE69319728T DE69319728T2 (en) 1992-05-23 1993-05-15 Combined vaccines that contain hepatitis B surface antigen and other antigens
DK97204034.9T DK0835663T3 (en) 1992-05-23 1993-05-15 Combined vaccines comprising Hepatitis B surface antigen and other antigens
SK1421-94A SK280702B6 (en) 1992-05-23 1993-05-15 Combined vaccines comprising hepatitis b surface antigen and other antigens
MYPI93000939A MY110665A (en) 1992-05-23 1993-05-20 Combined vaccines comprising hepatitis b surface antigen and other antigen
APAP/P/1993/000530A AP567A (en) 1992-05-23 1993-05-20 Combined vaccines comprising hepatitis B surface antigen and other antigens.
SI9300271A SI9300271A (en) 1992-05-23 1993-05-21 Combinated vaccine combinations containing hepatitis b as a vaccine component useful for treating hepatitis b infections
ZA933541A ZA933541B (en) 1992-05-23 1993-05-21 Vaccines
MA23192A MA22894A1 (en) 1992-05-23 1993-05-21 PROCESS FOR THE PREPARATION OF A VACCINE.
MX9302982A MX9302982A (en) 1992-05-23 1993-05-21 VACCINE COMPOSITION INCLUDING HEPATITIS B VACCINE COMPONENT, FOR THE TREATMENT OF HEPATITIS B INFECTIONS.
IL10577093A IL105770A (en) 1992-05-23 1993-05-21 Combined vaccine composition comprising hepatitis b surface antigen (hbsag)
CNB931073197A CN1136918C (en) 1992-05-23 1993-05-22 Vaccines
CNB031332374A CN1313152C (en) 1992-05-23 1993-05-22 Vaccines
FI945483A FI945483A (en) 1992-05-23 1994-11-22 Hepatitis B - combination vaccines containing surface antigens and other antigens
NO944475A NO309675B1 (en) 1992-05-23 1994-11-22 Combined vaccine comprising hepatitis B surface antigen
US08/755,927 US6013264A (en) 1992-05-23 1996-11-25 Vaccine
AU16480/97A AU709406C (en) 1992-05-23 1997-03-24 Combined vaccines comprising hepatitis B surface antigen and other antigens
HK98112444A HK1011290A1 (en) 1992-05-23 1998-11-30 Combined vaccines comprising hepatitis b surface antigen and other antigens
HK00100138.3A HK1021142A1 (en) 1992-05-23 1998-11-30 Combined vaccines comprising hepatitis b surface antigen and other antigens
AU50629/02A AU785433B2 (en) 1992-05-23 2002-06-25 Combined vaccines comprising hepatitis B surface antigen and other antigens
AU2007201162A AU2007201162A1 (en) 1992-05-23 2007-03-16 Combined vaccines comprising Hepatitis B surface antigen and other antigens
AU2010200249A AU2010200249B2 (en) 1992-05-23 2010-01-22 Combined vaccines comprising hepatitis B surface antigen and other antigens
LU91659C LU91659I2 (en) 1992-05-23 2010-03-03 Diphtheria, Tetanus, Pertussis, Hepatitis B, and Poliomyelitis Combined Vaccine (INFANRIX PENTA®)
LU91658C LU91658I2 (en) 1992-05-23 2010-03-03 Combined diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and Haemophilus influenzae type B conjugate vaccine (INFANRIX HEXA®)
CY1100003A CY2614B2 (en) 1992-05-23 2011-03-02 Combined vaccines comprising Hepatitis B surface and other antigens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929211081A GB9211081D0 (en) 1992-05-23 1992-05-23 Vaccines

Publications (1)

Publication Number Publication Date
GB9211081D0 true GB9211081D0 (en) 1992-07-08

Family

ID=10715999

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929211081A Pending GB9211081D0 (en) 1992-05-23 1992-05-23 Vaccines

Country Status (4)

Country Link
GB (1) GB9211081D0 (en)
PL (1) PL174077B1 (en)
RU (1) RU2287344C2 (en)
ZA (1) ZA933541B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103330936B (en) * 2013-07-18 2016-01-27 北京民海生物科技有限公司 A kind of Aluminium phosphate adjuvant in-situ method prepares the method for Hepatitis B virus vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294071A3 (en) * 1987-06-03 1990-08-01 Merck & Co. Inc. Hepatitis b vaccines made with pre-formed aluminum hydroxide gels, and processes thereof
JPH085804B2 (en) * 1988-04-28 1996-01-24 財団法人化学及血清療法研究所 Hepatitis A and B mixed adjuvant vaccine

Also Published As

Publication number Publication date
ZA933541B (en) 1994-06-21
PL174077B1 (en) 1998-06-30
RU2287344C2 (en) 2006-11-20

Similar Documents

Publication Publication Date Title
AP9300541A0 (en) Vaccines
AP9300530A0 (en) Vaccines
ZA947828B (en) Vaccines
AP9100332A0 (en) Vaccines
GB9325496D0 (en) Vaccines
GB9215233D0 (en) Vaccines
GB9213559D0 (en) Vaccines
GB9201023D0 (en) Vaccines
GB9214871D0 (en) Vaccines
GB9322702D0 (en) Vaccines
GB9202933D0 (en) Vaccines
GB9322808D0 (en) Vaccines
GB9226768D0 (en) Vaccines
GB9211081D0 (en) Vaccines
GB9211318D0 (en) Vaccines
GB9226283D0 (en) Vaccines
GB9221891D0 (en) Vaccines
GB9220360D0 (en) Vaccines
ZA935281B (en) Vaccines
GB9217635D0 (en) Vaccines
GB9216317D0 (en) Vaccines
GB9218833D0 (en) Vaccines
GB9213308D0 (en) Vaccine
GB9206789D0 (en) Vaccine
GB9307028D0 (en) Vaccine